R R

What Is Pradaxa?

Pradaxa is a prescription anticoagulant containing dabigatran etexilate, a direct thrombin inhibitor. It is used to reduce the risk of stroke in certain adults with atrial fibrillation and to treat or prevent selected blood clots in adults and children. Pradaxa is available in oral capsules and pediatric oral pellets, with different age requirements and dosing instructions. It reduces blood clot formation but does not directly dissolve an existing clot. Treatment requires careful attention to kidney function, bleeding risk, and medication interactions.

Link to This Resource Page

Provide a valuable resource to your clients or customers by linking to this resource page. Just place the following link on your website.

To display this...

What Is Pradaxa?

Pradaxa is a prescription anticoagulant containing dabigatran etexilate, a direct thrombin inhibitor. It is used to reduce the risk of stroke in certain adults with atrial fibrillation and to treat or prevent selected blood clots in adults and children. Pradaxa is available in oral capsules and pediatric oral pellets, with different age requirements and dosing instructions. It reduces blood clot formation but does not directly dissolve an existing clot. Treatment requires careful attention to kidney function, bleeding risk, and medication interactions.

read more about pradaxa ...

Copy this HTML:

Copy HTML Copied!

How Does Pradaxa Work?

Pradaxa contains dabigatran etexilate, a prodrug converted into active dabigatran after absorption. Dabigatran directly inhibits thrombin, an enzyme involved in converting fibrinogen into fibrin during blood clot formation. Blocking thrombin reduces fibrin production and clot development. This action helps prevent certain strokes and venous blood clots. Pradaxa does not work through the same mechanism as warfarin and does not generally require routine INR testing. Its anticoagulant activity can nevertheless cause serious bleeding, particularly in patients with impaired kidney function.

What Conditions Does Pradaxa Treat?

Pradaxa capsules are approved to reduce the risk of stroke and systemic embolism in adults with nonvalvular atrial fibrillation. They also treat deep vein thrombosis and pulmonary embolism in adults after initial injectable anticoagulation, reduce the risk of recurrent blood clots, and prevent certain clots following hip replacement surgery. Pediatric Pradaxa formulations treat venous thromboembolism and reduce recurrence after prior anticoagulant treatment. Age requirements differ between capsules and oral pellets. Pradaxa is contraindicated in patients with mechanical prosthetic heart valves and active pathological bleeding.

How Should Pradaxa Be Taken?

Pradaxa dosing depends on the indication, kidney function, age, and formulation. For adults with nonvalvular atrial fibrillation and creatinine clearance above 30 mL/min, the usual capsule dose is 150 mg orally twice daily. Adult treatment of deep vein thrombosis or pulmonary embolism generally uses 150 mg twice daily after five to ten days of injectable anticoagulation. Hip replacement prophylaxis follows a different schedule. Capsules must be swallowed whole and should not be opened, crushed, or chewed. Pediatric regimens are weight-based, and oral pellets are not interchangeable with capsules on a milligram-for-milligram basis.

What Are the Side Effects and Warnings of Pradaxa?

Bleeding is the primary safety risk associated with Pradaxa. Other adverse effects include indigestion, abdominal discomfort, and nausea. Pradaxa carries boxed warnings for increased clotting risk after premature discontinuation and spinal or epidural hematomas associated with certain procedures. Serious bleeding can occur, especially in patients with kidney impairment or those taking other medications that affect clotting. Idarucizumab is a specific reversal agent for dabigatran in certain emergencies. Black stools, vomiting blood, prolonged bleeding, sudden severe headache, or neurological symptoms require immediate medical attention.

Common Questions About Pradaxa

Is Pradaxa the same as dabigatran?

Yes. Pradaxa is a brand name for dabigatran etexilate, an oral direct thrombin inhibitor used for certain clotting conditions.

Does Pradaxa require regular INR testing?

Pradaxa generally does not require routine INR monitoring like warfarin. Kidney function and clinical bleeding risk still need assessment.

Can Pradaxa be used after hip replacement surgery?

Yes. Pradaxa capsules are approved to prevent deep vein thrombosis and pulmonary embolism in certain adults following hip replacement surgery.

Can Pradaxa cause serious bleeding?

Yes. Pradaxa can cause serious or fatal bleeding. Patients should seek immediate medical attention for significant bleeding or symptoms suggesting internal hemorrhage.

References

Dabigatran. LiverTox. https://www.ncbi.nlm.nih.gov/books/NBK547924/. Date Accessed November 2, 2026.

Dabigatran. MedlinePlus. https://medlineplus.gov/druginfo/meds/a610024.html. Date Accessed November 2, 2026.

Dabigatran. PubChem. https://pubchem.ncbi.nlm.nih.gov/compound/Dabigatran. Date Accessed November 2, 2026.

DailyMed - PRADAXA (dabigatran etexilate mesylate) capsule. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ba74e3cd-b06f-4145-b284-5fd6b84ff3c9. Date Accessed November 2, 2026.

Pradaxa. European Medicines Agency. https://www.ema.europa.eu/en/medicines/human/EPAR/pradaxa. Date Accessed November 2, 2026.